Caris Life Sciences to Present at Morgan Stanley Healthcare Conference

What Happened
Caris Life Sciences, Inc. (filed 8-K on 2026-09-14) announced under Item 7.01 (Regulation FD Disclosure) that it intends to use an investor presentation in meetings at the Morgan Stanley 24th Annual Global Healthcare Conference and at other investor events. The company said it will post the Investor Presentation on its investor relations website: https://investor.carislifesciences.com. The filing notes the website and presentation are not incorporated into the 8-K.

Key Details

• Filing date: September 14, 2026 (Current Report on Form 8-K, Item 7.01).
• Event: Morgan Stanley 24th Annual Global Healthcare Conference (presentation will be used at this conference and other investor meetings).
• Presentation availability: Will be posted on Caris Life Sciences’ investor relations site: https://investor.carislifesciences.com.
• Disclosure note: Website content and presentation are not incorporated by reference into the Form 8-K.

Why It Matters
This is a Regulation FD disclosure that makes the company’s investor presentation publicly available so all investors can access the same materials. The filing does not report earnings, financial results, or executive changes — it simply notifies investors where the company’s presentation will be used and where to find it. Investors who want management’s latest messaging or slide materials can review the posted presentation on the company’s investor website.